42 studies found for:    Open Studies | "Hypoglycemic Agents"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Hypoglycemic Agents" (42 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2;   Hypoglycemic Agents;   Diabetic Blood Glucose Monitoring;   Exercise
Interventions: Drug: MET + Vildagliptin Group;   Drug: MET + Glibenclamide Group
2 Not yet recruiting Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy
Condition: Type 2 Diabetes
Interventions: Other: 1: incretin-based therapy;   Other: 2: other antidiabetic
3 Unknown  Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Dietary Supplement: Vitamin C;   Drug: glyburide
4 Recruiting Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Alogliptin
5 Recruiting Oral Antidiabetic Agents in Pregnancy
Condition: Gestational Diabetes
Interventions: Drug: Metformin;   Drug: Glyburide
6 Recruiting Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Liraglutide;   Drug: Placebo
7 Recruiting A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients
Conditions: Type 1 Diabetes;   Severe Hypoglycemic Unawareness
Intervention: Biological: Islet Cell Transplant
8 Unknown  The Anti-Diabetic and Cholesterol-Lowering Effects of Cinnamon and Cassia Bark
Conditions: Type 2 Diabetes;   Hypercholesterolemia
Interventions: Dietary Supplement: Cinnamonforce;   Dietary Supplement: Placebo
9 Unknown  Antidiabetic Effects of Adding a DPP-4 Inhibitor (Sitagliptin) to Pre-Existing Treatment With an Incretin Mimetic (Liraglutide) in Patients With Type 2 Diabetes Treated With Metformin
Condition: Type 2 Diabetes
Interventions: Drug: Sitagliptin;   Drug: Placebo;   Other: Mixed meal test;   Drug: Liraglutide
10 Recruiting Effects of Antidiabetic Medications on the Postprandial State in Prediabetes
Conditions: Prediabetes;   Obesity
Interventions: Drug: Exenatide;   Drug: Saxagliptin;   Drug: Pioglitazone;   Other: Placebo
11 Not yet recruiting Effect of Ethanol Intoxication on the Anti-Hypoglycemic Action of Glucagon
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Ethanol;   Drug: Xeris Glucagon
12 Recruiting Glycemic Emergency Management (GEM); An App for Rapid Response to Hypoglycemic and Hyperglycemic Situations
Condition: Diabetes Mellitus
Interventions: Other: Experimental Group instructions for glucose management via App;   Other: Placebo Comparator general instructions
13 Not yet recruiting Evaluating the True Magnitude of HYPOglycemic Events After THE Initiation of Sulfonylurea
Condition: Type 2 Diabetes
Intervention: Other: Observational
14 Recruiting Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Placebo;   Drug: Exenatide
15 Recruiting Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Marketed Glucagon
Condition: Hypoglycemia
Interventions: Drug: ZP4207;   Drug: GlucaGen
16 Unknown  A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Repaglinide
17 Recruiting Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glargine U300 HOE901;   Drug: Insulin glargine HOE901
18 Recruiting Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Mellitus Patients Not Achieving Glycemic Targets on Basal Insulin With/Without Anti-Hyperglycemic Agents
Condition: Diabetes Mellitus, Type 2 (T2DM)
Interventions: Device: Bolus Insulin Patch (Calibra Finesse);   Device: Insulin Pen (Novo-Nordisk FlexPen®)
19 Recruiting Genetic Variation in the Transporters and Hypoglycemic Agents
Condition: Type 2 Diabetes
Intervention:
20 Unknown  Observational Registry for Basal Insulin Treatment Study (ORBIT)
Condition: Diabetes
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years